Stepwise minimization of the immunosuppressive therapy in pediatric liver transplantation: A conceptual approach towards operational tolerance

Acta Gastro-Enterologica Belgica

Volumn 68, Issue 3, 2005, Pages 320-322

  Reding, Raymond ^a   Gras, Jérémie ^a   Bourdeaux, Christophe ^a   Wieers, Grégoire ^a   Truong, Quang Dinh ^a   Latinne, Dominique ^a   Sokal, Etienne ^a   Janssen, Magda ^a   Lerut, Jan ^a   Otte, Jean Bernard ^a   De Ville De Goyet, Jean ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; CYCLOSPORIN A; OKT 3; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MICROEMULSION; PEDIATRIC SURGERY;

ADOLESCENT; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MULTICENTER STUDIES; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; T-LYMPHOCYTES; TACROLIMUS; TREATMENT OUTCOME;

EID: 26944481987     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. STARZL T.E., MARCHIORO T.L., ROWLANDS D.T. et al. Immunosuprression after experimental and clinical homotransplantation of the liver. Ann. Surg., 1964, 160: 411-439.
2. National Institutes of Health Consensus Conference Statement. Liver Transplantation-June 20-23, 1983. Hepatology, 1984, 4: 107S-110S.
3. STARZL T.E., DEMETRIS A.J., VAN THIEL D.H. Liver transplantation (first of two parts). N. Engl. J. Med., 1989, 321: 1014-1022.
4. ALAGILLE D. History of pediatric liver transplantation in Europe. Acta Gastroenterol. Belg., 2004, 67: 172-5.
5. REDING R., VRAUX H., DE VILLE DE GOYET J. et al. Monoclonal antibodies in prophylactic immunosuppression after liver transplantation. A randomized controlled trial comparing OKT3 and anti-IL2 receptor LO-Tact-1. Transplantation, 1993, 55: 534-541.
6. REDING R., FEYAERTS A., VRAUX H. et al. Prophylactic immunosuppression with anti-IL-2 receptor monoclonal antibody LO-Tact-1 versus OKT3 in liver allografting. A two year follow-up study. Transplantation, 1996, 61: 1406-1409.
7. REDING R., GRAS J., SOKAL E. et al. Steroid-free liver transplantation in children. Lancet, 2003, 362: 2068-2070.
8. REDING R., BOURDEAUX C., GRAS J., EVRARD V., BUTS J.P., CARLIER M. et al. The paediatric liver transplantation program at the Université catholique de Louvain Acta Gastroenterol. Belg., 2004, 67, 176-178.
9. KELLY D., JARA P., RODECK B. et al. The first European, prospective, randomised, multicentre study of tacrolimus and steroids compared with ciclosporin microemulsion, steroids and azathioprine in paediatric liver transplantation. Lancet, 2004, 364: 1054-1061.
10. OTTE J.B., DE VILLE DE GOYET J., REDING R. et al Pediatric liver transplantation: From the full-size liver graft to reduced, split, and living related liver transplantation. Pediatr. Surg. Int., 1998, 13: 308-318.
11. EVRARD V., OTTE J.B., SOKAL E. et al. Impact of surgical and immunological parameters in pediatric liver transplantation. A multivariate analysis in 500 consecutive recipients of primary grafts. Ann. Surg., 2004, 239: 272-280.
12. REDING R., DE VILLE DE GOYET J., DELBEKE I. et al. Pediatric liver transplantation with cadaveric or living related donors: Comparative results in 90 elective recipients of primary grafts. J. Pediatr., 1999, 134: 280-286.
13. SMETS F., BODEUS M., GOUBAU P. et al. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients. J. Hepatol., 2000, 32: 100-104.
14. SOKAL E., CARAGIOZOGLOU T., LAMY M.E. et al. Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation, 1993, 56: 1394-1398.
15. VO THI DIEM H., SOKAL E., JANSSEN M. et al. Steroid withdrawal after pediatric liver transplantation. A long-term follow-up study in 109 recipients. Transplantation, 2003, 75: 1664-1670.
16. SNOVER D.C., SIBLEY R.K., FREESE D.K. et al. Orthotopic liver Transplantation: A pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology, 1984, 4: 1212-1222.
17. DOUSSET B., HUBSCHER S.G., PADBURY R.T. et al. Acute liver allograft rejection. Is treatment always necessary? Transplantation, 1993, 55: 529-534.
18. WANG C., SUN J., SHEIL A.G. et al. A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation, 2001, 72: 44-51.
19. REDING R., DAVIES H.F.S. Revisiting liver transplant immunology: From the concept of immune engagement to the dualistic pathway paradigm. Liver Transpl., 2004, 1081-1086.
20. STARZL T.E., MURASE N., ABU-ELMAGD K. et al. Tolerogenic immunosuppression for organ transplantation. Lancet, 2003, 361: 1502-1510.
21. LI Y, KOSHIBA T., YOSHIZAWA A. et al. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am. J. Transplant., 2004, 4: 2118-2125.